Navigation Links
3SBio Announces Changes to its Board of Directors
Date:3/10/2010

Safe Harbor Statement

This press release contains statements of a forward-looking nature. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. The accuracy of these statements may be impacted by a number of business factors and uncertainties that could cause actual results to differ materially from those projected or anticipated, including factors related to: the ability of the company to avoid disruption to its business caused by changes to the Board and management; the ability of the company to recruit and retain suitable members of the Board and management; and other risks outlined in 3SBio's filings with the Securities and Exchange Commission. 3SBio does not undertake any obligation to update this forward-looking information, except as required under applicable law.

    For more information, please contact:

    Investor Contacts

    3SBio Inc.
     Bo Tan
     Chief Financial Officer
     Tel:   +86-24-2581-1820
     Email: ir@3SBio.com

     Tom Folinsbee
     Director of Investor Relations
     Tel:   +852-8191-6991
     Email: ir@3SBio.com

'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
2. 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
3. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
4. 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
5. 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
6. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
7. 3SBio Inc. Announces Unaudited Third Quarter 2009 Results
8. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
9. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
10. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
11. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Australian prostate cancer technology company Minomic ... prize recognising ,outstanding, science that uses its patented antibody. ... a novel prostate cancer diagnostic test known as MiCheck® ... taking out the peer-reviewed Australian Museum Eureka Science Prize ... This prize is awarded for ground breaking research ...
(Date:9/2/2015)... Biovista Inc. freut sich, ... 2015 bekanntgeben zu können. Hierbei handelt es sich ... Biovista unterstützt mit seiner Möglichkeit der Analyse ... Krankheiten als denen, für die ein Medikament ursprünglich ... Team bei der Wylder Nation Foundation bei der ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... and life science research, today unveiled Genedata Screener ® version 13.0 at ... in-vitro screening brings to market a rich set of new capabilities. Screener now ...
(Date:9/1/2015)... YORK , Sept. 1, 2015 /PRNewswire-USNewswire/ ... of cancer death in American men. One ... cancer and 233,000 new cases are diagnosed annually. ... experts are using a powerful new technique, ... small and large cancer lesions, treating only the ...
Breaking Biology Technology:Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4
... Biovista Inc. today,announced that BVA-101, its drug ... in the MOG-induced Experimental Allergic,Encephalomyelitis (EAE) murine model ... in MS and is aimed at neuroprotection, was ... no toxic effects in this well,established model of ...
... Vermillion, Inc. (OTC Bulletin Board: VRML) today announced ... relief under Chapter 11 of the United States Bankruptcy ... District of Delaware ("Bankruptcy Court") in Wilmington, Delaware. ... it focuses on obtaining regulatory clearance respecting the company,s ...
... Shire plc (LSE: SHP,NASDAQ: SHPGY ) announces ... District,Court for the Southern District of New York against ... patents: U.S. Patent No.,5,968,976 (",976 Patent"); and U.S. Patent ... The lawsuit was filed in response to an ANDA ...
Cached Biology Technology:Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis 2Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 2Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 3Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 4Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 5Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents 2
(Date:8/24/2015)... VIEW, Calif. , Aug. 24, 2015  Based on ... Sullivan recognizes DERMALOG with the 2015 African Biometrics Company of ... and has achieved substantial commercial success in Africa ... Nigeria , where it has implemented one of the ... 23 banks as well as the Central Bank of ...
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/18/2015)... Aug. 17, 2015 Research and Markets ... the "Global Biometric Authentication & Identification Market: ... & Forecast, 2015-2020" report to their offering. ... identification systems market is expected to grow at ... 2020 and generate over $25 billion (approximately) by ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... sound counterintuitive to use a microbial protein to improve ... that to protect themselves from potentially toxic nanoparticles in ... future could potentially do the same thing on a ... National Laboratory, UC Berkeley and Lawrence Berkeley National Laboratory ...
... Purdue University have shown that common bacteria can deliver ... to precisely position sensors, drugs or DNA for the ... The approach represents a potential way to overcome hurdles ... they could be used as an alterative technology for ...
... Life Sciences, a member of the Roche group, and ... they have used the company’s Genome Sequencer™ system to ... samples from an earlier performed clinical trial. The ... Yale University School of Medicine and the VA CT ...
Cached Biology News:Microbes at work cleaning up the environment 2Bacteria ferry nanoparticles into cells for early diagnosis, treatment 2Bacteria ferry nanoparticles into cells for early diagnosis, treatment 3454 sequencing identifies HIV drug resistance at early stage 2
... System is ideal for developing single ... reagents. The Luminex 100 Instrument System ... version 1.7, the XY platform and ... $2000 in free Beadlyte products if ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Madin-Darby bovine kidney (MDBK) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: